MedPath
FDA Approval

Telmisartan

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Effective Date
March 6, 2023
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Telmisartan(40 mg in 1 1)

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

A-S Medication Solutions

A-S Medication Solutions

830016429

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Telmisartan

Product Details

NDC Product Code
50090-5490
Application Number
ANDA202397
Marketing Category
ANDA (C73584)
Route of Administration
ORAL
Effective Date
March 22, 2018
MAGNESIUM STEARATEInactive
Code: 70097M6I30Class: IACT
Code: U5SYW473RQClass: ACTIBQuantity: 40 mg in 1 1
MANNITOLInactive
Code: 3OWL53L36AClass: IACT
MEGLUMINEInactive
Code: 6HG8UB2MUYClass: IACT
SODIUM HYDROXIDEInactive
Code: 55X04QC32IClass: IACT
POVIDONE, UNSPECIFIEDInactive
Code: FZ989GH94EClass: IACT
© Copyright 2025. All Rights Reserved by MedPath